Evidence map›Paper›PMID 35242007›Full record

ArticleFrontiers in neuroscience2022

Identification of Region-Specific Cytoskeletal and Molecular Alterations in Astrocytes of

Elena Albizzati, Elena Florio, Federica Miramondi, Irene Sormonta, Nicoletta Landsberger, Angelisa Frasca

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. MeCP2 gene therapy ameliorates disease phenotype in mouse model for Pitt Hopkins syndrome.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  6. Article
  7. iScience · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Elena AlbizzatiDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Elena FlorioDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Federica MiramondiDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Irene SormontaDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Nicoletta LandsbergerDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Angelisa FrascaDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
University of Milan · ITIstituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rett syndrome (RTT) is a neurodevelopmental disorder that represents the most common genetic cause of severe intellectual disability in females. Most patients carry mutations in the X-linked

Indexed as

astrocytecytoskeletonheterogeneityMeCP2Rett syndrome (RTT)

Identifiers

PMID35242007
PMCPMC8886113
OpenAlexW4225999907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.